Dytor 10 mg Cipla

£8.00

Dytor 10 mg Cipla is a torasemide-based diuretic research compound available for laboratory investigation of cardiovascular and fluid balance mechanisms in controlled research environments.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Dytor 10 mg Cipla
Dytor 10 mg Cipla
£8.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

About Dytor

Dytor 10 mg Cipla is a torasemide-containing pharmaceutical preparation designed for in-vitro laboratory research into loop diuretic mechanisms and cardiovascular physiology studies. Manufactured by Cipla, this research compound provides investigators with a standardised tool for examining the molecular pathways involved in sodium-potassium-chloride co-transporter inhibition and its effects on fluid homeostasis. Research laboratories studying renal physiology and cardiovascular drug mechanisms frequently utilise this compound to investigate the complex interactions between electrolyte balance and hemodynamic parameters in controlled experimental settings.

Laboratory investigators examining diuretic mechanisms can access this compound through Stroid UK Shop, which maintains comprehensive research chemical supplies for UK-based research institutions. The compound’s pharmaceutical-grade formulation ensures consistent experimental results when studying loop diuretic pathways and their modulation of renal tubular transport processes.

Laboratory Applications

Research applications for this compound span multiple areas of cardiovascular and renal physiology investigation. Scientists studying electrolyte transport mechanisms utilise torasemide-containing preparations to examine the inhibition of the Na-K-2Cl co-transporter in the thick ascending limb of Henle’s loop. This research contributes to understanding fundamental renal physiology and the molecular basis of diuretic action in experimental models.

Cardiovascular research teams investigate how loop diuretic compounds affect preload reduction and ventricular filling pressures in laboratory settings. The compound serves as a valuable research tool for studying the relationship between diuretic therapy and cardiac output modulation. Researchers can explore these mechanisms alongside other cardiovascular compounds available in our specialised cardiovascular research category, while also examining complementary research areas such as selective androgen receptor modulators and bioactive peptides for comprehensive physiological studies.

Technical Specifications

Dytor 10 mg Cipla Research Specifications
Compound Torasemide
Strength 10 mg per unit
Manufacturer Cipla Pharmaceuticals
Form Tablet
Classification Loop diuretic research compound
Storage Room temperature, dry conditions
Molecular Class Pyridine-sulfonylurea derivative
Research Use Cardiovascular and renal studies

Compliance Statement

Dytor 10 mg Cipla is supplied exclusively for in-vitro research purposes and laboratory investigation of cardiovascular mechanisms. This product is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure proper institutional oversight and safety protocols when conducting studies with this compound. All research applications should comply with relevant institutional review board requirements and laboratory safety guidelines for pharmaceutical research compounds.

Related